IDEAYA Biosciences, Inc. — Director's Dealing 2021

Jun 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEAYA Biosciences, Inc. (IDYA)
CIK: 0001676725
Period of Report: 2021-06-10

Reporting Person: Hampton Malcolm Garret (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-10	Stock Option (right to buy)	$21.66	A	11000	Acquired	2031-06-09	Common Stock (11000)	Direct

Footnotes

F1: 100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date.